Re-treatment of patients with chronic hepatitis C virus genotype 4 infection with pegylated interferon and ribavirin: a meta-analysis

Por Zhang, Bing, Nguyen, Nghia H, Yee, Brittany E, Yip, Benjamin, Nguyen, Mindie H
Publicado no BMJ Open Gastroenterol (2015)

Lower response to simeprevir and sofosbuvir in HCV genotype 1 in routine practice compared with clinical trials

Por Yee, Brittany E, Nguyen, Nghia H, Jin, Minjuan, Lutchman, Glen, Lim, Joseph K, Nguyen, Mindie H
Publicado no BMJ Open Gastroenterol (2016)

Tolerability and effectiveness of sofosbuvir and simeprevir in the post-transplant setting: systematic review and meta-analysis

Por Nguyen, Nghia H, Yee, Brittany E, Chang, Christine, Jin, Minjuan, Lutchman, Glen, Lim, Joseph K, Nguyen, Mindie H
Publicado no BMJ Open Gastroenterol (2016)

Meta-analysis: Influence of host and viral factors in patients with chronic hepatitis C genotype 4 treated with pegylated interferon and ribavirin

Por Yee, Brittany E., Nguyen, Nghia H., Zhang, Bing, Vutien, Philip, Wong, Carrie R., Lutchman, Glen A., Nguyen, Mindie H.
Publicado em 2014

Meta-analysis: Superior treatment response in Asian patients with HCV genotype 6 versus 1 with pegylated interferon and ribavirin

Por Nguyen, Nghia H., McCormack, Shelley A., Vutien, Philip, Yee, Brittany E., Devaki, Pardha, Jencks, David, Nguyen, Mindie H.
Publicado no Intervirology (2015)

Sustained virological response and its treatment predictors in hepatitis C virus genotype 4 compared to genotypes 1, 2, and 3: a meta-analysis

Por Yee, Brittany E, Nguyen, Nghia H, Zhang, Bing, Lin, Derek, Vutien, Philip, Wong, Carrie R, Lutchman, Glen A, Nguyen, Mindie H
Publicado no BMJ Open Gastroenterol (2015)